|

EGCG and Quinine Sulfate Vaginal Suppository Clinical Trials

1 actively recruiting trial

Pipeline

Phase 2: 1

Top Sponsors

  • Amplexd Therapeutics, Inc.1

Indications

  • Cervical Abnormalities1
  • High-risk HPV (Any Strain)1
  • LSIL, Low Grade Squamous Intraepithelial Lesion1
  • ASC-US1
  • Uterine Cervical Dysplasia1

Other1 trial

Phase II Study of Dysplasix™ Intravaginal Suppositories in Patients Patients With High-Risk HPV and Mild Cervical Cytologic Abnormalities
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.